DAC Goes the Extra Mile at Site Solutions Summit as a 5K Sponsor

DALLAS (October 7, 2014)— DAC Patient Recruitment Services, an Imperial company and leader in patient recruitment and retention for global clinical trials, announces its sponsorship of SCRS Thanks the Heroes – a 5K Fun Run & Walk honoring patients who participate in clinical trials. Hosted by the Society for Clinical Research Sites (SCRS) as part of its 9th Annual Site Solutions Summit, the event is set for Sunday, October 12, from 7:05 to 8 a.m. on the grounds of the Omni Amelia Island Plantation Resort in Florida. “We are proud to partner with SCRS for this event to celebrate individuals who give their time and efforts to help advance public health through research participation,” said Steve Swanson, DAC president and Imperial CEO. “In nine short years, the summit has evolved from a concept to a dynamic organization driving tangible change, and I look forward to many more initiatives that support continued growth.” With a membership comprising trial sponsors, CROs and trial support service providers, SCRS is the first trade organization fully dedicated to engaging in discussions and developing action plans that advance clinical research sites and the research industry at-large. DAC joined SCRS as a Global Impact Partner (GIP) last year with Swanson’s appointment to the SCRS GIP Board. In this capacity, he interfaces with the SCRS Leadership Council to help set strategic direction for the society and to identify the work streams most significant to the success of sites. This year’s summit is expected to draw nearly 400 sites, more than 70 sponsors and CRO executives, and up to 40 exhibitors. The program includes 10+ hours of networking events, 10 master workshops, 40 interactive sessions, and the opportunity to earn up to 15 continuing education units. Proceeds from SCRS Thanks the Heroes will benefit the Center for Information & Study on Clinical Research Participation (CISCRP) Medical Heroes campaign. Launched in 2008, this public service initiative seeks to transform the image of clinical research participants from “guinea pigs” to medical heroes, while raising research awareness. About DAC DAC Patient Recruitment Services is proud to be a part of the Imperial Family of Companies—a clinical research support organization also comprising ClinicaLingua Translation Services and Imperial Graphics. Together, these three vertically integrated brands focus on patient recruitment, translation services, and site material production, fulfillment and global distribution. Working in synergy with our sister companies, we provide start-to-finish clinical trial solutions with the power of three companies through the convenience of one contact and one contract. For more information, visit dacprs.com or call 800.451.0322. About SCRS SCRS is a global trade organization founded in 2012 which represents over 1,500 research sites, including 26,000 research professionals; 15,000 investigators and 9,000 research staff, in 39 countries. SCRS’ mission is to unify the voice of the global clinical research site community for site sustainability. SCRS has become an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Sites, as well as companies that sponsor or support the work conducted at the clinical research sites, will also benefit from membership and partnership. Visit www.myscrs.org. For more information, contact: Felicia Fuller (469) 916-8604 [email protected]

Free Webinar

From Patient Adherence to Manufacturing Ease - Why Softgels Make Sense for Rx

Join Thermo Fisher Scientific’s upcoming webinar to learn why softgels offer numerous benefits for Rx drug development, including enhanced bioavailability, patient compliance and easy scale-up. Register Today.

Suggested Articles

Polyphor is developing an inhaled version of murepavadin, which targets Pseudomonas aeruginosa infections, but is currently given intravenously.

Japanese pharma Astellas is looking to offload a series of unwanted research projects ahead of Thanksgiving; if you want one, it’s made it very easy.

A re-engineered adenovirus prolonged survival in mouse models of metastatic lung cancer and cleared tumors in about 35% of the animals.